Preclinical Imaging of Therapy Response Using Metabolic and Apoptosis Molecular Imaging

Early after therapy, 2-deoxy-2-[F-18]fluoro-d-glucose ([F-18]FDG) imaging is not always reliable due to the influx of inflammatory cells while apoptosis imaging offers a direct and early measurement of therapy effects. This study uses an improved apoptosis probe (Tc-99m-hAnxA5) in combination with [F-18]FDG imaging to evaluate therapy response.

Publication year:2011

BOF-keylabel:yes

IOF-keylabel:yes

BOF-publication weight:1

CSS-citation score:1

Authors:International

Authors from:Higher Education